Advanced search
Publication Cover
Immunopharmacology and Immunotoxicology Volume 42, 2020 - Issue 4
Submit an article Journal homepage
311
Views
6
CrossRef citations to date
0
Altmetric
Brief Report

A case of asthma with Behcet’s disease: successful treatment with omalizumab and its effects on recurrent aphthous lesions

Arzu Didem Yalcina Department of Internal Medicine, Allergy and Clinical Immunology, Academia Sinica, Genomics Research Center, Taipei, TaiwanCorrespondence[email protected]
&
Ata Nevzat Yalcinb Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology, Akdeniz University, Antalya, Turkey
Pages 379-382 | Received 17 Dec 2019, Accepted 24 Jun 2020, Published online: 07 Jul 2020

References

  • Hatemi G, Merkel PA, Hamuryudan V, et al. Outcome measures used in clinical trials for behçet syndrome: a systematic review. J Rheumatol. 2014;41(3):599–612.
  • Elshahaly M, Latif IAE, Bassiouni H. Clinical characteristics of Behcet's disease in 453 Egyptian patients suffering from uveitis with gender comparison. Curr Rheumatol Rev. 2019; 6. Doi: 10.2174/1573397115666191007102317
  • Yalcin AD, Uçar S, Gumuslu S, et al. Effects of omalizumab on eosinophil cationic peptide, 25-hydroxyvitamin-D, IL-1β and sCD200 in cases of Samter's syndrome: 36 months follow-up. Immunopharmacol Immunotoxicol. 2013;35(4):524–527.
  • Yalcin AD, Cilli A, Bisgin A, et al. Omalizumab is effective in treating severe asthma in patients with severe cardiovascular complications and its effects on sCD200, d-dimer, CXCL8, 25-hydroxyvitamin D and IL-1β levels. Expert Opin Biol Ther. 2013;13(9):1335–1341.
  • Yalcin AD, Uzun R. Anti-IgE significantly changes circulating interleukin-25, vitamin-D and Interleukin-33 levels in patients with allergic asthma. Curr Pharm Des. 2019;29. DOI: 10.2174/1381612825666190930095725
  • Bonacini M, Soriano A, Zerbini A, et al. Higher frequencies of lymphocytes expressing the natural killer group 2D receptor in patients with Behçet disease. Front Immunol. 2018;9:2157.
  • Emmi G, Becatti M, Bettiol A, et al. Behçet's syndrome as a model of thrombo-inflammation: the role of neutrophils. Front Immunol. 2019;10:1085.
  • Ho PP, Lee LY, Zhao X, et al. Autoimmunity against fibrinogen mediates inflammatory arthritis in mice. J Immunol. 2010;184(1):379–390.
  • Yalcin AD. A case of Netherton syndrome: successful treatment with omalizumab and pulse prednisolone and its effects on cytokines and immunoglobulin levels. Immunopharmacol Immunotoxicol. 2016;38(2):162–166.
  • Yalcin AD, Celik B, Gumuslu S. D-dimer levels decreased in severe allergic asthma and chronic urticaria patients with the omalizumab treatment. Expert Opin Biol Ther. 2014;14(3):283–286.
  • Yalcin AD, Bisgin A, Gorczynski RM. IL-8, IL-10, TGF-β, and GCSF levels were increased in severe persistent allergic asthma patients with the anti-IgE treatment. Mediators Inflamm. 2012;2012:720976.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.